Objective-Disturbed flow (DF) is well-known to induce endothelial dysfunction and synergistically with plasma dyslipidemia facilitate plaque formation. Little is known, however, about the synergistic impact of DF and dyslipidemia on endothelial biomechanics. Our goal was to determine the impact of DF on endothelial stiffness and evaluate the role of dyslipidemia/oxLDL (oxidized low-density lipoprotein) in this process. Approach and Results-Endothelial elastic modulus of intact mouse aortas ex vivo and of human aortic endothelial cells exposed to laminar flow or DF was measured using atomic force microscopy. Endothelial monolayer of the aortic arch is found to be significantly stiffer than the descending aorta (4.2+1.1 versus 2.5+0.2 kPa for aortic arch versus descending aorta) in mice maintained on low-fat diet. This effect is significantly exacerbated by short-term high-fat diet (8.7+2.5 versus 4.5+1.2 kPa for aortic arch versus descending aorta). Exposure of human aortic endothelial cells to DF in vitro resulted in 50% increase in oxLDL uptake and significant endothelial stiffening in the presence but not in the absence of oxLDL. DF also increased the expression of oxLDL receptor CD36 (cluster of differentiation 36), whereas downregulation of CD36 abrogated DF-induced endothelial oxLDL uptake and stiffening. Furthermore, genetic deficiency of CD36 abrogated endothelial stiffening in the aortic arch in vivo in mice fed either low-fat diet or high-fat diet. We also show that the loss of endothelial stiffening in CD36 knockout aortas is not mediated by the loss of CD36 in circulating cells. and contractility. [11] [12] [13] In terms of the mechanism, we have shown oxLDL-induced endothelial stiffening is mediated by the uptake of oxidized lipids [13] [14] [15] and can be fully attributed to the activation of the RhoA/ROCK/MLCP/MLC2 (Rho-associated protein kinase/myosin light-chain phosphatase/myosin regulatory light chain 2) cascade. 16 In the current study, we investigate the regional heterogeneity of endothelial stiffness between the atherosusceptible region of the aortic arch (AA) and atheroresistant region of the descending aorta (DA) and determine the impact of proatherogenic and antiatherogenic flow environments on endothelial uptake of oxLDL and EC stiffness.
A therosclerotic plaques develop preferentially in arterial regions that are exposed to nonunidirectional disturbed flow (DF). The predisposition of these regions to atherosclerosis is attributed to the hemodynamic forces that act on the endothelium: unidirectional fluid shear stress in uniform straight vessels is atheroprotective, whereas the recirculating disturbed low flow at bifurcations is proatherogenic. [1] [2] [3] Multiple studies showed that exposure to DF induces a variety of proinflammatory genes and pathways, whereas laminar flow (LF) is antiinflammatory. [2] [3] [4] It is also well-known that although DF alone causes endothelial dysfunction and predisposes the region to plaque development, it is the combination of DF and dyslipidemia that results in the development of atherosclerotic plaques. Little is known, however, about the mechanisms of the synergistic effects of DF and dyslipidemia on endothelial properties.
See accompanying editorial on page 4
Oxidative modifications of LDL (oxLDL [oxidized lowdensity lipoprotein]) play a major role in dyslipidemia-induced endothelial dysfunction and the onset of atherosclerosis. Briefly, oxLDL accumulates in atherosclerotic lesions and was found to correlate with cardiovascular events. 5, 6 Furthermore, mouse models of genetic deficiency in endothelial scavenger receptors that recognize oxLDL were shown to have atheroprotective effects. 7, 8 OxLDL was also found to be cytotoxic to endothelial cells (ECs), to impair the integrity of the endothelial barrier, impair the production of nitric oxide, increase reactive oxygen species, and promote the release of proinflammatory cytokines. 6, 9, 10 Our earlier studies showed that exposure to oxLDL results in a significant increase in endothelial stiffness and contractility. [11] [12] [13] In terms of the mechanism, we have shown oxLDL-induced endothelial stiffening is mediated by the uptake of oxidized lipids [13] [14] [15] and can be fully attributed to the activation of the RhoA/ROCK/MLCP/MLC2 (Rho-associated protein kinase/myosin light-chain phosphatase/myosin regulatory light chain 2) cascade. 16 In the current study, we investigate the regional heterogeneity of endothelial stiffness between the atherosusceptible region of the aortic arch (AA) and atheroresistant region of the descending aorta (DA) and determine the impact of proatherogenic and antiatherogenic flow environments on endothelial uptake of oxLDL and EC stiffness.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

High Cholesterol Diet Results in Endothelial Stiffening: Enhanced Effect in Atherosusceptible Regions of the Aorta
The impact of high cholesterol/high-fat diet (HFD) on endothelial stiffness in vivo in the AA and the DA was tested using a mouse model of diet-induced endothelial dysfunction described earlier. 17 Briefly, 6-week-old C57BL/6 male mice were fed HFD for 1 month resulting in a significant increase in weight gain (15% versus 33%), total cholesterol, LDL, and oxLDL ( Figure 1A ), as compared with mice fed low-fat diet (LFD). Notably, although there was a low lipid content in the aortic tissues of LFD-fed mice, as assessed by Oil Red-O staining of histological sections ( Figure 1C , with PECAM-1 [platelet-endothelial cell adhesion molecule-1] staining shown in Figure 1B ), there was a significant increase in lipid accumulation in the AA as compared with the DA ( Figure 1D ). Furthermore, we performed liquid chromatography-electrospray ionization tandem mass spectrometric analysis of cholesterol and cholesterol esters in the AA and DA tissues from mice on both LFD and HFD ( Figure 1E) . A small increase in free cholesterol content in the AA regions was observed in 5 out of 8 mice on LFD and in 4 out of 4 mice on HFD but it was not statistically significant ( Figure 1E ; left 2 panels). We also observed a significant increase in the level of cholesterol esters in the AA regions, which was exacerbated by a HFD ( Figure 1E ; right 2 panels).
Endothelial stiffness was evaluated by measuring the elastic modulus of the endothelial monolayer of intact arteries using atomic force microscopy. For all animals, the stiffness of the endothelium was measured in the DA and AA regions (6-10 distinct sites measured for each region for each animal, microindentation depth of 0.5-1 μm, 10% to 15% of the cell height). The integrity of the endothelial monolayer was confirmed by en face staining with an endothelial marker, PECAM-1, showing the characteristic endothelial morphology in the DA and AA regions ( Figure 1F ). First, we compared the elastic moduli of the endothelium of DA and AA regions of aortas isolated from mice maintained on LFD ( Figure 1G ; top row). These data show that the endothelium of the AA region has a higher elastic modulus (increased stiffness) as compared with the endothelium of the DA, as represented by the rightward shift in the histogram. Average elastic moduli for DA and AA regions for each mouse in this experimental group are shown in Figure 1H . Introducing HFD resulted in significant stiffening of the endothelium in both the DA and AA regions, with the effect clearly enhanced in the AA region ( Figure 1G , bottom row; Figure 1H ). All mice were sex and age-matched and experiments on LFD and HFD-fed mice were performed in parallel.
Differential Effects of LF and DF on OxLDL-Induced Endothelial Stiffening
Since our previous studies showed that endothelial stiffness is significantly increased in cells exposed to oxLDL [11] [12] [13] and since it was recently shown that oscillatory flow results in increased oxLDL uptake in coronary ECs, 18 we hypothesized that an increase in endothelial stiffness in the arch regions of the aortas may be mediated by enhanced oxLDL uptake and oxLDL-induced endothelial stiffening. To test this hypothesis, we compared oxLDL uptake in human aortic ECs (HAECs) exposed to unidirectional LF versus nonunidirectional DF using a microfluidic flow chamber with a step barrier ( Figure  IA in the online-only Data Supplement; Figure 2A ), a modification of a step barrier flow chamber described earlier. 19 Using computational fluid dynamics analysis, it was determined that for the specific parameters of the step width and height, the device created a recirculation region of 2 mm after the step ( Figure IB Our results show that oxLDL uptake in HAECs exposed to DF was significantly higher than in cells exposed to LF ( Figure 2B and 2C) . Uptake of 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate (DiI-oxLDL; 1 μg/mL) was measured in HAECs grown in 0.2% gelatin-coated microfluidics devices, in cells exposed to 10 to 12 dyn/cm 2 of laminar/unidirectional or <3 dyn/cm 2 recirculating/DF for 48 hours, by quantifying the oxLDL-specific fluorescence. The oxLDL concentration used for uptake experiments is based on the reported range of oxLDL in human plasma (from 0.2-0.4 to 7-31 μg/mL, K D of oxLDL binding to CD36 (cluster of differentiation 36) ≈3-7 μg/mL at 4°C). An increase in oxLDL uptake was also observed in HAECs exposed for 48 hours to proatherogenic DF, as compared with atheroprotective LF waveforms created by a cone and plate apparatus that generates physiologically-relevant shear stress patterns (eg, 21 ; Figure 2D through 2F). Furthermore, we performed liquid chromatography-electrospray ionization tandem mass spectrometric analysis of cholesterol and oxysterol contents in HAECs exposed to atheroprotective versus proatherogenic flows. This analysis shows that although no significant increase was observed in cholesterol content ( Figure 2G , inset), there was a significant increase in the level of several oxysterols 7-ketocholesterol, 5α,6α-epoxycholestanol, and 27-OH-cholesterol ( Figure 2G ).
Increased oxLDL uptake in the DF regions resulted in a significant increase in endothelial stiffness ( Figure 2H and 2I). The elastic modulus was measured after 48 hours exposure to flow in the presence or absence of 10 µg/mL oxLDL in the medium. The upper panel of the chamber was removed after the cessation of flow to allow the atomic force microscopy tip access to the cell surface. Regions exposed to LF versus DF were identified by the proximity to the barrier. No difference in the elastic modulus of HAECs was observed in DF versus LF regions in the absence of oxLDL ( Figure 2H and 2I). We also observed that oxLDL-induced HAECs stiffening was dose dependent under static conditions ( Figure III in the online-only Data Supplement). Also, independent experiments showed that although cells grown and flow treated on a collagen substrate are stiffer overall than those on a gelatin or fibronectin substrate, there was no difference in the cellular elastic modulus between DF versus LF regions in each condition in the absence of oxLDL ( Figure IV in the online-only Data Supplement).
OxLDL-Induced Endothelial Stiffening Under DF Is Mediated by Increased Expression of CD36
To elucidate the mechanism of increased oxLDL uptake and endothelial stiffening under DF conditions, we first tested the impact of differential flow patterns on the mRNA expression of 2 major endothelial oxLDL receptors, CD36 and Lox1 (lectin-like oxidized low-density lipoprotein receptor-1). Both CD36 and Lox1 are expressed in HAECs and mRNA expression of both increased in response to proatherogenic flow as compared with atheroprotective flow ( Figure 3A) . Notably, the level of CD36 mRNA expression was 70-fold higher than Lox1. Also, as we showed previously, 16 CD36 is expressed in HAECs on the protein level ( Figure 3B ) but is lower than in human microvascular ECs (Figure V in the online-only Data Supplement). Moreover, protein expression of CD36 is higher in cells exposed to DF (proatherogenic) when compared with cells exposed to LF (atheroprotective in Figure 3B , negative and positive controls of CD36 expression in CHO cells are shown in Figure V in the online-only Data Supplement). In addition, Figure 3B shows no difference in CD36 expression between the static condition and either of the flow conditions, which is also observed on the mRNA level as well (data not shown). No significant effect between the static and the flow conditions was observed for Lox1 mRNA (data not shown) and protein ( Figure VI in the online-only Data Supplement) expression levels. Furthermore, expression of CD36 on the plasma membrane of HAECs was confirmed by immunostaining and z-stack confocal imaging in nonpermeabilized cells labeled with a plasma membrane marker ( Figure 3C ) and by TIRF (total internal reflection fluorescence microscopy) microscopy which showed CD36 on the membrane ( Figure 3D , left: TIRF, right: epifluorescence). Protein expression of CD36 was also significantly increased in DF, as determined by immunostaining HAECs exposed to flow in the step barrier chamber in the presence of oxLDL ( Figure 3E and 3F) . The specificity of the CD36 fluorescence was verified using CD36-targeting siRNAs demonstrating that downregulation of the protein dramatically decreased the signal. The knockdown effect was verified by quantitative polymerase chain reaction and by Western Blot analysis ( Figure VII in the online-only Data Supplement).
Our further studies show that oxLDL uptake by HAECs is mediated by CD36. Cell surface binding and internalization of DiI-oxLDL is dependent on CD36 expression as evidenced by reduced DiI-oxLDL in HAECs treated with CD36-targeting siRNA ( Figure 4A and 4B) . Next, we assessed the role of CD36 in the DF-induced increase in oxLDL uptake. The downregulation of CD36 (using 2 different CD36-targeting siRNAs) significantly decreased the uptake of oxLDL under both laminar and recirculating/DF and abrogated the increase in oxLDL uptake in response to DF ( Figure 4C and 4D) . Downregulation of CD36 expression also abrogated oxLDL-induced endothelial stiffening both under LF and DF and eliminated the differential effect between the 2 flow environments on endothelial stiffness ( Figure 4E and 4F) . No change in endothelial elastic modulus was observed between LF and DF in the absence of oxLDL ( Figure 4F ). Also, downregulation of CD36 had no effect on endothelial stiffness in cells not exposed to oxLDL. In contrast, downregulation of Lox1 expression had no effect on oxLDL uptake, leaving the effect of DF fully preserved ( Figure VIII in the online-only Data Supplement). 
Endothelial Stiffening in the AA Critically Depends on CD36 Expression
Next, we applied mechanistic insights gleaned from our current studies investigating DF/oxLDL-induced endothelial stiffening in vitro to elucidate the mechanism of endothelial stiffening in atherosusceptible aortic regions in vivo.
To determine a potential contribution of the oxLDL/CD36 pathway to EC stiffening, we utilized the mouse model that is globally deficient in the CD36 receptor. Initially, studies in wild-type (WT) mice showed a small but significant increase in CD36 expression in the AA versus DA regions, as determined by immunostaining of the histological sections ( Figure 5A and 5B). Immunohistological staining of CD36 was confirmed by significantly reduced staining in the histological sections of the aortic tissues isolated from CD36 knockout mice compared with the WT mice ( Figure IX in the online-only Data Supplement). Also, although there was an increase in lipid depositions in the arch in CD36 knockout mice (0.3±0.1% area in DA and 0.9±0.1% area in AA), the level of the lipid deposition in general was significantly lower than in the WT tissues (1.2±0.1% area versus 2.5±0.1% area in DA and AA, respectively). In the first series of experiments, aortas were isolated from WT and CD36 knockout age-matched male mice maintained on LF diet (5-6 months old). Similar to the effect observed in younger mice described above, there was significant endothelial stiffening in the AA versus DA in WT mice ( Figure 5C and 5D ). In contrast, no stiffening was observed in the endothelium of the arch regions in CD36 knockout mice ( Figure 5C and 5D ). Furthermore, a separate cohort of 2-month-old CD36 knockout mice were fed HF diet or maintained on LF diet for 1 month, the same regiment used in WT mice described above. Similarly to WT mice, CD36 knockout mice gained significant amount of weight when fed HFD and had elevated levels of oxLDL in the plasma ( Figure 5E ). However, in contrast to WT mice, no difference in endothelial elastic modulus was observed between AA and DA regions in CD36 knockout mice maintained both on LFD or HFD ( Figure 5F ). Interestingly, the range of endothelial elastic moduli in CD36 knockout mice on both LF and HF diets was similar to the DA region in WT mice on LFD, despite a similar increase in body weight and plasma oxLDL concentrations.
Finally, to exclude the possibility that the decrease in endothelial stiffening in CD36 knockout mice could be caused by a trans effect of the loss of CD36 in circulating cells, we performed a bone marrow transplant study in which WT marrow was transplanted into CD36 knockout mice. Briefly, we harvested bone marrow from WT mice expressing a Ly5.1 marker to identify the donor cells after the implantation, isolated the monocytes and injected them into irradiated WT and CD36 knockout mice. The percent incorporation of WT donor macrophages, 1 month post transplantation, was over 95% for the recipient WT and CD36 knockout mice ( Figure 6A ). Elastic modulus measurements of endothelial monolayers of the recipient WT mice continued to show an increased stiffening effect in the AA as compared with the DA. In comparison, endothelial elastic modulus values from both the DA and the AA from CD36 knockout mice were low despite successful incorporation of donor WT macrophages ( Figure 6B and 6C) . This shows that the relative softening seen in CD36 knockout mice is not a trans effect of CD36 loss in circulating cells.
Discussion
This study shows that proatherogenic DF induces endothelial stiffening by facilitating endothelial uptake of oxLDL via CD36 scavenger receptor, and demonstrates a novel mechanism of synergistic interaction between proatherogenic flow and dyslipidemia that alters the endothelial biomechanical phenotype in atherosusceptible regions of the aorta.
An increase in vascular stiffness is associated with aging and cardiovascular disease. 22 Our study, however, is focused not on the stiffness of the vascular wall, dominated by extracellular matrix and layers of smooth muscle cells, but on stiffness of the endothelial monolayer, which by itself can be a major factor in regulating barrier function and adhesion and transmigration of immune cells. 23, 24 To test the effects of dyslipidemia, we used a mouse model of diet-induced obesity in WT mice, known to induce endothelial dysfunction and considered to have translational impact when compared with human obesity. 17, 25 Our findings demonstrate that short-term plasma dyslipidemia is sufficient to induce significant endothelial stiffening of intact aortas and strongly exacerbate endothelial stiffening in AA observed in animals on LFD.
Currently, there is only scarce information about endothelial stiffness in intact arteries. A recent study by Collins et al 26 showed increased endothelial response to force in the AA as compared with the DA in WT mice, an effect that was attributed to increased fibronectin depositions. Our data are in agreement with this study in terms of increased endothelial stiffness in the arch. We provide evidence, however, that this effect is mediated by increased endothelial uptake of oxidized lipids. First, it is abrogated by genetic deficiency of a scavenger receptor CD36 and exacerbated by plasma dyslipidemia, also in CD36-dependent way. It is also supported by our observations in vitro that oxLDL is required for the DF-induced stiffening. Notably, elastic modulus measured in our study reflects endothelial deformability/stiffness without additional intervention, whereas previous study measured the stiffening response to a local application of force via microbeads, a significantly different parameter, which could be mediated by a different mechanism. Both parameters may have significant physiological consequences.
The well-documented effects of substrate stiffness on endothelial responses 22 and biomechanical properties, 27 also raise a possibility that endothelial stiffening in AA could be an indirect result of stiffening of the vascular wall. However, although we cannot fully exclude this possibility, our in vitro data indicate that endothelial stiffening develops as a result of DF-induced increase in oxLDL uptake in the absence of any changes in the substrate stiffness. Together with demonstrating lipid accumulation in the AA even in the LFD and the abrogation of the stiffening effect by CD36 deficiency, our data suggest that it is the lipid uptake that is responsible for endothelial stiffening.
Another important finding is that exposure to DF per se created as a region of recirculation does not induce endothelial stiffening as compared with LF in the same flow channel, which does not contradict previous studies showing that exposure to LF results in endothelial stiffening as compared with static environment. 28 These observations underscore the importance of comparing different physiologically-relevant flow patterns in the analysis of the effect of flow on endothelial biomechanics.
In terms of the mechanism of oxLDL uptake by aortic endothelium, our data show that an increase in oxLDL uptake under DF results from increased expression of CD36, whereas Lox1 plays no detectable role. Consistently, we have recently shown that it is CD36 and not Lox1 that is required for oxLDLinduced endothelial stiffening under static conditions. 13 It was initially surprising because most previous studies focused on Lox1 as the primary oxLDL receptor in ECs 10,29 but the current study fully support our previous findings. Moreover, Figure 5 . Endothelial stiffening in the aortic arch critically depends on CD36 (cluster of differentiation 36) expression even with high-fat diet (HFD). A, Representative images of sectioned descending aorta (DA; left) and aortic arch (AA; right) immunostained for CD36. B, Average CD36 specific staining in mouse aortas (n=3, 3-4 sections per mouse). C, Histograms of endothelial elastic modulus in the DA and AA regions in 5-to 6-mo-old wild-type (WT) and CD36 knockout (KO) male mice. D, Average elastic modulus for the DA and AA regions from WT and CD36 KO mice. E, Average body weights (left, n=7-10 mice) and oxLDL (oxidized low-density lipoprotein) plasma levels (right, n=6 mice) in low-fat diet (LFD) vs HFD fed mice. F, Average elastic modulus values for the DA and AA regions from LFD and HFD fed CD36 KO mice. For all mice, 6 to 10 sites (50-90 atomic force microscopy measurements) were measured per sample, n=5 mice per condition. *P<0.05.
an increase in CD36 expression in response to DF, which results in enhanced oxLDL uptake and stiffening, suggests that it can contribute to endothelial dysfunction in DF. This conclusion is further supported by the in vivo observations showing that CD36 deficiency prevents endothelial stiffening in dyslipidemia. The next major question is to determine the mechanistic link between the binding of oxLDL to CD36, oxLDL internalization and activation of the RhoA/ROCK/MLCP/ MLC2 cascade, which we have recently shown to induce endothelial stiffening. 16 Our most recent study suggests that oxLDL induces RhoA activation by causing its dissociation from the RhoA inhibitory protein GDI-1 (GDP dissociation inhibitor-1), 30 one of the major regulators of RhoA in ECs. 31, 32 Furthermore, because it is known that GDI-1 interacts with RhoA via a hydrophobic pocket and can be displaced by specific lipids, we propose that it is the incorporation of oxidized lipids that is responsible for the dissociation of GDI-1 from RhoA resulting in the activation of RhoA cascade and EC stiffening. In this scenario, the role of CD36 is to mediate internalization of oxLDL leading to the incorporation of oxidized lipids into the membrane. This hypothesis is also consistent with our earlier studies showing that direct incorporation of specific oxysterols, oxidized phospholipids or even cholesterol depletion is sufficient to induced EC stiffening. [11] [12] [13] 15 However, it is important to note that activation of CD36 may also result in RhoA activation via multiple signaling pathways, including generation of ROS (reactive oxygen species), activation of Src phosphorylation cascades or transactivation of VEGF (vascular endothelial growth factor). 33 Further studies are needed to address these possibilities.
